Parathyroid Hormone (PTH)/PTH-related Peptide Type 1 Receptor (PPR) Signaling in Osteocytes Regulates Anabolic and Catabolic Skeletal Responses to PTH
Open accessAbstract
Parathyroid hormone (PTH) is the only Food and Drug Administration-approved anabolic agent to treat osteoporosis; however, the cellular targets of PTH action in bone remain controversial. PTH modulates bone turnover by binding to the PTH/PTH-related peptide (PTHrP) type 1 receptor (PPR), a G-protein-coupled receptor highly expressed in bone and kidneys. Osteocytes, the most abundant cells in adult bone, also express PPR. However, the physiological relevance of PPR signaling in osteocytes remains to be elucidated. Toward this goal, we generated mice with PPR deletion in osteocytes (Ocy-PPRKO). Skeletal analysis of these mice revealed a significant increase in bone mineral density and trabecular and cortical bone parameters. Osteoblast activities were reduced in these animals, as demonstrated by decreased collagen type I α1 mRNA and receptor activator of NF-κB ligand (RANKL) expression. Importantly, when subjected to an anabolic or catabolic PTH regimen, Ocy-PPRKO animals demonstrated blunted skeletal responses. PTH failed to suppress SOST /Sclerostin or induce RANKL expression in Ocy-PPRKO animals compared with controls. In vitro , osteoclastogenesis was significantly impaired in Ocy-PPRKO upon PTH administration, indicating that osteocytes control osteoclast formation through a PPR-mediated mechanism. Taken together, these data indicate that PPR signaling in osteocytes is required for bone remodeling, and receptor signaling in osteocytes is needed for anabolic and catabolic skeletal responses. Background: Osteocytes, the most abundant cells in adult bone, express PPR. Results: Mice with constitutive PPR deletion in osteocytes demonstrate blunted anabolic and catabolic bone responses and the inability to recruit osteoblasts and osteoclasts upon PTH administration. Conclusion: PPR in osteocytes is needed for a full skeletal response to PTH administration. Significance: PPR signaling in osteocytes is necessary for PTH-driven anabolic effects during osteoporosis therapy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
When PTHR1 is deleted, RANKL release and subsequent osteoclastogenesis do not occur.
“In contrast, when PTHR1 is deleted, RANKL release and subsequent osteoclastogenesis do not occur.81”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · see citing works
Guidelines for assessment of bone microstructure in rodents using micro–computed tomography
Bouxsein, M., Boyd, S. K., Christiansen, B., Guldberg, R. E., Jepsen, K. J., & Müller, R. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.141 · Cited by 4,461 · see citing works
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287 · see citing works
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2452 · Cited by 1,778 · see citing works
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366 · cited 5× · see citing works
“OEBE were treated with 100nM hPTH(1-34) or 10μM forskolin.”
BackgroundMethodInfluentialMatrix-embedded cells control osteoclast formation
Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304 · see citing works
A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide
Jüppner, H., Abou‐Samra, A., Freeman, M. W., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F., Hock, J. M., Potts, J. T. J., Kronenberg, H. M., et al. (1991) · Science · doi:10.1126/science.1658941 · Cited by 1,249 · see citing works
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P. K., PARFITT, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,042 · see citing works
SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor
Semënov, M., Tamai, K., & He, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504308200 · Cited by 771 · see citing works
Bellido, T., Ali, A., Gubrij, I. B., Plotkin, L. I., Fu, Q., O’Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2005-0239 · Cited by 640 · see citing works
Dobnig, H., & Turner, R. T. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628403 · Cited by 614 · see citing works
Targeting the Wnt/β-Catenin Pathway to Regulate Bone Formation in the Adult Skeleton
Baron, R., & Rawadi, G. (2007) · Endocrinology · doi:10.1210/en.2007-0270 · Cited by 584 · see citing works
Self-citationDemonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation
Qing, H., Ardeshirpour, L., Divieti Pajevic, P., Dusevich, V., Jähn, K., Kato, S., Wysolmerski, J., & Bonewald, L. F. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1567 · Cited by 489 · see citing works
Self-citationControl of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
O’Brien, C. A., Plotkin, L. I., Galli, C., Goellner, J. J., Gortázar, A. R., Allen, M. R., Robling, A. G., Bouxsein, M., Schipani, E., Turner, C. H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002942 · Cited by 389 · see citing works
PTH Differentially Regulates Expression of RANKL and OPG
Huang, J. C., Sakata, T., Pfleger, L. L., Bencsik, M., Halloran, B. P., Bikle, D. D., & Nissenson, R. A. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301226 · Cited by 379 · see citing works
PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps
Kobayashi, T., Chung, U., Schipani, E., Starbuck, M. W., Karsenty, G., Katagiri, T., GOAD, D. L., Lanske, B., & Kronenberg, H. M. (2002) · Development · doi:10.1242/dev.129.12.2977 · Cited by 320 · see citing works
Kim, S. W., Pajevic, P. D., Selig, M., Barry, K. J., Yang, J.-Y., Shin, C. S., Baek, W.-Y., Kim, J.-E., & Kronenberg, H. M. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1665 · Cited by 266 · see citing works
Self-citationControl of the SOST Bone Enhancer by PTH Using MEF2 Transcription Factors
Leupin, O., Krämer, I., Collette, N. M., Loots, G. G., Natt, F., Kneissel, M., & Keller, H. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070804 · Cited by 248 · see citing works
Parathyroid Hormone for the Prevention of Bone Loss Induced by Estrogen Deficiency
Finkelstein, J. S., Klibanski, A., Schaefer, E. H., Hornstein, M. D., Schiff, I., & Neer, R. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412153312404 · Cited by 245 · see citing works
Schaffler, M. B., & Kennedy, O. D. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-012-0105-4 · Cited by 227 · see citing works
Fu, Q., Jilka, R. L., Manolagas, S. C., & O’Brien, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208494200 · Cited by 224 · see citing works
LRP5 Mutations Linked to High Bone Mass Diseases Cause Reduced LRP5 Binding and Inhibition by SOST
Semënov, M. V., & He, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609509200 · Cited by 222 · see citing works
PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling
Rhee, Y., Allen, M. R., Condon, K., Lezcano, V., Ronda, A. C., Galli, C., Olivos, N., Passeri, G., O'Brien, C. A., Bivi, N., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.304 · Cited by 208 · see citing works
Powell, W. F., Barry, K. J., Tulum, I., Kobayashi, T., Harris, S. E., Bringhurst, F. R., & Pajevic, P. D. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0308 · Cited by 202 · see citing works
Self-citationMyelopoiesis is regulated by osteocytes through Gsα-dependent signaling
Fulzele, K. S., Krause, D. S., Panaroni, C., Saini, V., Barry, K. J., Liu, X., Lotinun, S., Baron, R., Bonewald, L. F., Feng, J. Q., et al. (2012) · Blood · doi:10.1182/blood-2012-06-437160 · Cited by 152 · see citing works
Self-citationBonnet, N., Conway, S. J., & Ferrari, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203085109 · Cited by 149 · see citing works
Bone histomorphometry: Proposed system for standardization of nomenclature, symbols, and units
PARFITT, A. M. (1988) · Calcified Tissue International · doi:10.1007/bf02556360 · Cited by 141 · see citing works
Targeted deletion of Sost distal enhancer increases bone formation and bone mass
Collette, N. M., Genetos, D. C., Economides, A. N., Xie, L., Shahnazari, M., Yao, W., Lane, N. E., Harland, R. M., & Loots, G. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207188109 · Cited by 132 · see citing works
Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts
Genetos, D. C., Toupadakis, C. A., Raheja, L. F., Wong, A., Papanicolaou, S. E., Fyhrie, D. P., Loots, G. G., & Yellowley, C. E. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22559 · Cited by 119 · see citing works
Mef2c deletion in osteocytes results in increased bone mass
Krämer, I., Baertschi, S., Halleux, C. M., Keller, H., & Kneissel, M. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1492 · Cited by 85 · see citing works
Pharmacogenomics of Osteoporosis: A Pathway Approach
Riancho, J. A., & Hernández, J. L. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.50 · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Parathyroid hormone: anabolic and catabolic actions on the skeleton
Silva, B. C. C., & Bilezikian, J. P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.03.005 · Cited by 564 · see citing works
Bone remodeling: an operational process ensuring survival and bone mechanical competence
Bolamperti, S., Villa, I., & Rubinacci, A. (2022) · Bone Research · doi:10.1038/s41413-022-00219-8 · Cited by 482 · see citing works
Role and mechanism of action of sclerostin in bone
Delgado‐Calle, J., Sato, A. Y., & Bellido, T. (2016) · Bone · doi:10.1016/j.bone.2016.10.007 · Cited by 449 · see citing works
Jepsen, K. J., Silva, M. J., Vashishth, D., Guo, X.-D. E., & van der Meulen, M. C. H. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2539 · Cited by 338 · see citing works
The osteocyte as a signaling cell
Delgado‐Calle, J., & Bellido, T. (2021) · Physiological Reviews · doi:10.1152/physrev.00043.2020 · Cited by 269 · see citing works
Regulation of Bone Remodeling by Parathyroid HormonePreprint
Wein, M. N., & Kronenberg, H. M. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031237 · Cited by 243 · see citing works
Osteocytic signalling pathways as therapeutic targets for bone fragility
Plotkin, L. I., & Bellido, T. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.71 · Cited by 206 · see citing works
Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota
Li, J.-Y., Yu, M., Pal, S., Tyagi, A. M., Dar, H., Adams, J., Weitzmann, M. N., Jones, R. M., & Pacifici, R. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133473 · Cited by 198 · see citing works
Furuya, M., Kikuta, J., Fujimori, S., Seno, S., Maeda, H., Shirazaki, M., Uenaka, M., Mizuno, H., Iwamoto, Y., Morimoto, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02541-w · Cited by 173 · see citing works
SIKs control osteocyte responses to parathyroid hormone
Wein, M. N., Liang, Y., Göransson, O., Sundberg, T. B., Wang, J., Williams, E. A., O’Meara, M. J., Govea, N., Beqo, B., Nishimori, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms13176 · Cited by 161 · see citing works
Self-citationThe skeletal cell‐derived molecule sclerostin drives bone marrow adipogenesis
Fairfield, H. E., Falank, C. R., Harris, E., DeMambro, V., McDonald, M. M., Pettitt, J. A., Mohanty, S. T., Croucher, P. I., Krämer, I., Kneissel, M., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25976 · Cited by 140 · see citing works
The Role of Osteocytes in Age-Related Bone Loss
Jilka, R. L., & O’Brien, C. A. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0297-0 · Cited by 136 · see citing works
Xiong, J., Piemontese, M., Thostenson, J. D., Weinstein, R. S., Manolagas, S. C., & O’Brien, C. A. (2014) · Bone · doi:10.1016/j.bone.2014.06.006 · Cited by 127 · see citing works
Osteoporosis and Bone Mass Disorders: From Gene Pathways to Treatments
Rivadeneira, F., & Mäkitie, O. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.03.006 · Cited by 124 · see citing works
Prideaux, M., Wijenayaka, A. R., Kumarasinghe, D. D., Ormsby, R. T., Evdokiou, A., Findlay, D. M., & Atkins, G. J. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9879-y · Cited by 125 · see citing works
Ben-awadh, A. N., Delgado-Calle, J., Tu, X., Kuhlenschmidt, K., Allen, M. R., Plotkin, L. I., & Bellido, T. (2014) · Endocrinology · doi:10.1210/en.2014-1046 · Cited by 114 · see citing works
Appelman‐Dijkstra, N. M., & Papapoulos, S. E. (2015) · Drugs · doi:10.1007/s40265-015-0417-7 · Cited by 116 · see citing works
Delgado-Calle, J., Tu, X., Pacheco-Costa, R., McAndrews, K., Edwards, R., Pellegrini, G. G., Kuhlenschmidt, K., Olivos, N., Robling, A., Peacock, M., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3011 · Cited by 114 · see citing works
Physiological and Pharmacological Roles of PTH and PTHrP in Bone Using Their Shared Receptor, PTH1R
Martin, T. J., Sims, N. A., & Seeman, E. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab005 · Cited by 112 · see citing works
Gardella, T. J., & Vilardaga, J. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009464 · Cited by 109 · see citing works
Li, J., D’Amelio, P., Robinson, J. W., Walker, L. D., Vaccaro, C., Luo, T., Tyagi, A. M., Yu, M., Reott, M. A., Sassi, F., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.012 · Cited by 104 · see citing works
Melatonin is a potential drug for the prevention of bone loss during space flight
Ikegame, M., Hattori, A., Tabata, M. J., Kitamura, K., Tabuchi, Y., Furusawa, Y., Maruyama, Y., Yamamoto, T., Sekiguchi, T., Matsuoka, R., et al. (2019) · Journal of Pineal Research · doi:10.1111/jpi.12594 · Cited by 89 · see citing works
Sheng, M. H. ‐., Lau, K. ‐. W., & Baylink, D. J. (2014) · Journal of Bone Metabolism · doi:10.11005/jbm.2014.21.1.41 · Cited by 86 · see citing works
Li, J., Yu, M., Tyagi, A. M., Vaccaro, C., Hsu, E., Adams, J., Bellido, T., Weitzmann, M. N., & Pacifici, R. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3600 · Cited by 81 · see citing works
Pacifici, R. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12969 · Cited by 83 · see citing works
Hormonal and systemic regulation of sclerostin
Drake, M. T., & Khosla, S. (2017) · Bone · doi:10.1016/j.bone.2016.12.004 · Cited by 77 · see citing works
Yu, M., D’Amelio, P., Tyagi, A. M., Vaccaro, C., Li, J., Hsu, E., Buondonno, I., Sassi, F., Adams, J., Weitzmann, M. N., et al. (2017) · EMBO Reports · doi:10.15252/embr.201744421 · Cited by 69 · see citing works
Ricarte, F. R., Hénaff, C. L., KOLUPAEVA, V. G., Gardella, T. J., & Partridge, N. C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004751 · Cited by 69 · see citing works
The Role of IL-17 and TH17 Cells in the Bone Catabolic Activity of PTH
Pacifici, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00057 · Cited by 66 · see citing works
IGF‐1 signaling mediated cell‐specific skeletal mechano‐transduction
Tian, F., Wang, Y., & Bikle, D. D. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23767 · Cited by 67 · see citing works
Kumar, S., Wang, M., Kim, A. S., McDonald, M. M., & Girgis, C. M. (2025) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjaf037 · Cited by 68 · see citing works
Parathyroid Hormone Signaling in Osteocytes
Wein, M. N. (2017) · JBMR Plus · doi:10.1002/jbm4.10021 · Cited by 64 · see citing works
Ansari, N., Ho, P. W. M., Crimeen‐Irwin, B., Poulton, I. J., Brunt, A. R., Forwood, M. R., Pajevic, P. D., Gooi, J. H., Martin, T. J., & Sims, N. A. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3291 · Cited by 61 · see citing works
Self-citationInterplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism
Maria, C. S., Cheng, Z., Li, A., Wang, J., Shoback, D., Tu, C., & Chang, W. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.12.004 · Cited by 61 · see citing works
Miyagawa, K., Yamazaki, M., Kawai, M., Nishino, J., Koshimizu, T., Ohata, Y., Tachikawa, K., Mikuni‐Takagaki, Y., Kogo, M., Ozono, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093840 · Cited by 59 · see citing works
Yan, Y., Wang, L., Ge, L., & Pathak, J. L. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00564-9 · Cited by 57 · see citing works
Ex Vivo Organ Cultures as Models to Study Bone Biology
Bellido, T., & Delgado‐Calle, J. (2020) · JBMR Plus · doi:10.1002/jbm4.10345 · Cited by 57 · see citing works
Maycas, M., McAndrews, K., Sato, A. Y., Pellegrini, G., Brown, D. M., Allen, M. R., Plotkin, L. I., Gortázar, A. R., Esbrit, P., & Bellido, T. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3007 · Cited by 54 · see citing works
The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases
Pathak, J. L., Bravenboer, N., & Klein‐Nulend, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00405 · Cited by 53 · see citing works
Saito, H., Gasser, A. S., Bolamperti, S., Maeda, M., Matthies, L., Jähn, K., Long, C. L., Schlüter, H., Kwiatkowski, M., Saini, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08778-x · Cited by 53 · see citing works
Self-citationThe osteocyte and its osteoclastogenic potential
Marahleh, A., Kitaura, H., Ohori, F., Noguchi, T., & Mizoguchi, I. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1121727 · Cited by 53 · see citing works
PTH Signaling in Osteoprogenitors Is Essential for B-Lymphocyte Differentiation and Mobilization
Panaroni, C., Fulzele, K. S., Saini, V., Chubb, R., Pajevic, P. D., & Wu, J. Y. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2581 · Cited by 49 · see citing works
Self-citationCo-administration of Antiresorptive and Anabolic Agents: A Missed Opportunity
Seeman, E., & Martin, T. J. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2496 · Cited by 48 · see citing works
The fragile elderly hip: Mechanisms associated with age-related loss of strength and toughness
REEVE, J., & Loveridge, N. (2014) · Bone · doi:10.1016/j.bone.2013.12.034 · Cited by 48 · see citing works
Is There a Governing Role of Osteocytes in Bone Tissue Regeneration?
Cao, W., Helder, M. N., Bravenboer, N., Wu, G., Jin, J., Bruggenkate, C. M. T., Klein‐Nulend, J., & Schulten, E. A. J. M. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00610-6 · Cited by 47 · see citing works
N-cadherin Restrains PTH Activation of Lrp6/β-catenin Signaling and Osteoanabolic Action
Revollo, L., Kading, J. C., Jeong, S. Y., Li, J., Salazar, V. S., Mbalaviele, G., & Civitelli, R. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2323 · Cited by 45 · see citing works
Yin, L., Sun, C., Zhang, J., Li, Y., Wang, Y., Bai, L., & Lei, Z. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1639430 · Cited by 45 · see citing works
PTH and the Regulation of Mesenchymal Cells within the Bone Marrow Niche
Liu, H., Liu, L., & Rosen, C. J. (2024) · Cells · doi:10.3390/cells13050406 · Cited by 42 · see citing works
Ankle-Brachial Index and Bone Turnover in Patients on Dialysis
London, G. M., Marchais, S. J., Guérin, A. P., & de Vernejoul, M. C. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014020169 · Cited by 39 · see citing works
Carbonic anhydrase III protects osteocytes from oxidative stress
Shi, C., Uda, Y., Dedic, C., Azab, E., Sun, N., Hussein, A. I., Petty, C. A., Fulzele, K. S., Mitterberger, M. C., Zwerschke, W., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700485rr · Cited by 37 · see citing works
Self-citationRole of Gut Microbiota in the Skeletal Response to PTH
Pacifici, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa895 · Cited by 43 · see citing works
Pacheco‐Costa, R., Davis, H. M., Sorenson, C., Hon, M. C., Hassan, I., Reginato, R. D., Allen, M. R., Bellido, T., & Plotkin, L. I. (2015) · Bone · doi:10.1016/j.bone.2015.09.011 · Cited by 37 · see citing works
gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation
Standal, T., Johnson, R. W., McGregor, N. E., Poulton, I. J., Ho, P. W. M., Martin, T. J., & Sims, N. A. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0424 · Cited by 36 · see citing works
T Cell–Expressed CD40L Potentiates the Bone Anabolic Activity of Intermittent PTH Treatment
Robinson, J. W., Li, J., Walker, L. D., Tyagi, A. M., Reott, M. A., Yu, M., Adams, J., Weitzmann, M. N., & Pacifici, R. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2394 · Cited by 35 · see citing works
Genetic Approaches To Identifying Novel Osteoporosis Drug Targets
Brommage, R. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25179 · Cited by 35 · see citing works
Meakin, L. B., Todd, H., Delisser, P., Galea, G. L., Moustafa, A., Lanyon, L. E., Windahl, S. H., & Price, J. S. (2017) · Bone · doi:10.1016/j.bone.2017.02.009 · Cited by 34 · see citing works
Yu, E. W.-Y., Kumbhani, R., Siwila-Sackman, E., DeLelys, M. E., Preffer, F. I., Leder, B. Z., & Wu, J. Y. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2171 · Cited by 33 · see citing works
Sato, T., Verma, S. K., Khatri, A., Dean, T., Göransson, O., Gardella, T. J., & Wein, M. N. (2020) · JBMR Plus · doi:10.1002/jbm4.10441 · Cited by 29 · see citing works
Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications
Vilardaga, J., Clark, L. J., White, A. D., Sutkevičiu̅tė, I., Lee, J. Y., & Bahar, İ. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac032 · Cited by 31 · see citing works
He, S., Xue, M., Liu, C., Xie, F., & Bai, L. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.03.003 · Cited by 30 · see citing works
Novel approaches to the treatment of osteoporosis
Appelman‐Dijkstra, N. M., & Papapoulos, S. E. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.07.003 · Cited by 29 · see citing works
Kim, J.-H., Kim, A. R., Choi, Y. H., Kim, A., Sohn, Y., Woo, G., Cha, J., Bak, E., & Yoo, Y. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1438-2 · Cited by 29 · see citing works
Johnson, R. W., Sun, Y., Ho, P. W. M., Chan, A. S. M., Johnson, J. A., Pavlos, N. J., Sims, N. A., & Martin, T. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00241 · Cited by 29 · see citing works
Liu, Z., Kennedy, O. D., Cardoso, L., Basta‐Pljakic, J., Partridge, N. C., Schaffler, M. B., Rosen, C. J., & Yakar, S. (2015) · The FASEB Journal · doi:10.1096/fj.15-275859 · Cited by 26 · see citing works
Thouverey, C., & Caverzasio, J. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2762 · Cited by 26 · see citing works
Saedi, A. A., Stupka, N., & Duque, G. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_358 · Cited by 26 · see citing works
Ardura, J. A., Portal‐Núñez, S., Alonso, V., Bravo, B., & Gortázar, A. R. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.07.014 · Cited by 25 · see citing works
The effect of osteoporosis treatment on bone mass
Appelman‐Dijkstra, N. M., Oei, H. L. D. W., Veldhuis‐Vlug, A. G., & Winter, E. M. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101623 · Cited by 26 · see citing works
The PTH-Gαs-Protein Kinase A Cascade Controls αNAC Localization To Regulate Bone Mass
Pellicelli, M., Miller, J. A., Arabian, A., Gauthier, C., Akhouayri, O., Wu, J. Y., Kronenberg, H. M., & St‐Arnaud, R. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01434-13 · Cited by 24 · see citing works
Bone Development and Remodeling
Maes, C., & Kronenberg, H. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00060-3 · Cited by 25 · see citing works
Treatment with intermittent PTH increases Wnt10b production by T cells in osteoporotic patients
D’Amelio, P., Sassi, F., Buondonno, I., Fornelli, G., Spertino, E., D’Amico, L., Marchetti, M., Lucchiari, M., Roato, I., & Isaia, G. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3189-8 · Cited by 24 · see citing works
Shirakawa, J., Harada, H., Noda, M., & Ezura, Y. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-0083-5 · Cited by 20 · see citing works
Kedlaya, R., Kang, K. S., Hong, J. M., Bettagere, V., Lim, K., Horan, D. J., Pajevic, P. D., & Robling, A. G. (2016) · Endocrinology · doi:10.1210/en.2015-1587 · Cited by 23 · see citing works
Self-citationLoss of the PTH/PTHrP receptor along the osteoblast lineage limits the anabolic response to exercise
Gardinier, J. D., Daly‐Seiler, C. S., Rostami, N., Kundal, S., & Zhang, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211076 · Cited by 22 · see citing works
Anabolic actions of PTH in murine models: two decades of insights
Zweifler, L. E., Koh, A. J., Daignault‐Newton, S., & McCauley, L. K. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4389 · Cited by 22 · see citing works
Role of cortical bone in hip fracture
REEVE, J. (2017) · BoneKEy Reports · doi:10.1038/bonekey.2016.82 · Cited by 21 · see citing works
Uda, Y., Saini, V., Petty, C. A., Alshehri, M., Shi, C., Spatz, J. M., Santos, R., Newell, C. M., Huang, T. Y., Kochen, A., et al. (2021) · Aging · doi:10.18632/aging.203808 · Cited by 20 · see citing works
Self-citationFulzele, K. S., Dedic, C., Lai, F., Bouxsein, M., Lotinun, S., Baron, R., & Pajevic, P. D. (2018) · Bone · doi:10.1016/j.bone.2018.09.021 · Cited by 20 · see citing works
Self-citationDanz, J. C., & Degen, M. (2025) · Frontiers in Oral Health · doi:10.3389/froh.2025.1472711 · Cited by 22 · see citing works
Kaito, T., Morimoto, T., Kanayama, S., Otsuru, S., Kashii, M., Makino, T., Kitaguchi, K., Furuya, M., Chijimatsu, R., Ebina, K., et al. (2016) · Bone Reports · doi:10.1016/j.bonr.2016.07.003 · Cited by 19 · see citing works
Gohin, S., Carriero, A., Chenu, C., Pitsillides, A. A., Arnett, T. R., & Marenzana, M. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3164 · Cited by 18 · see citing works
Gonciulea, A. R., & de Beur, S. M. J. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9316-1 · Cited by 18 · see citing works
Nagata, Y., Imanishi, Y., Tateishi, T., Miyaoka, D., Kurajoh, M., Arnold, A., & Emoto, M. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac027 · Cited by 19 · see citing works
Hrdlicka, H. C., Pereira, R. C., Shin, B., Yee, S., Deymier, A. C., Lee, S., & Delany, A. M. (2020) · Bone · doi:10.1016/j.bone.2020.115779 · Cited by 17 · see citing works
The Optimal Duration of PTH(1–34) Infusion Is One Hour per Day to Increase Bone Mass in Rats
Shimizu, M., Noda, H., Joyashiki, E., Nakagawa, C., Asanuma, K., Hayasaka, A., Kato, M., Nanami, M., Inada, M., Miyaura, C., et al. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00756 · Cited by 16 · see citing works
The microbiome adds to the complexity of parathyroid hormone action on bone
Khosla, S. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135712 · Cited by 15 · see citing works
The Notch pathway regulates the bone gain induced by PTH anabolic signaling
Delgado-Calle, J., McAndrews, K., Wu, G. J., Orr, A. L., Ferrari, A. J., Tu, X.-L., Srinivasan, V., Roodman, G. D., Ebetino, F., Boeckman, R. K., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101807r · Cited by 13 · see citing works
Skowrońska‐Jóźwiak, E., Lewandowski, K. C., Adamczewski, Z., Krawczyk‐Rusiecka, K., & Lewiñski, A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/948384 · Cited by 15 · see citing works
Bone-Remodeling Transcript Levels Are Independent of Perching in End-of-Lay White Leghorn Chickens
Dale, M. D., Mortimer, E., Kolli, S., Achramowicz, E., Borchert, G. M., Juliano, S. A., Halkyard, S. D., Sietz, N., Gatto, C., Hester, P. Y., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16022663 · Cited by 15 · see citing works
Dedic, C., Hung, T. S., Shipley, A. M., Maeda, A., Gardella, T., Miller, A. L., Divieti Pajevic, P., Kunkel, J. G., & Rubinacci, A. (2018) · Bone · doi:10.1016/j.bone.2018.07.020 · Cited by 14 · see citing works
Self-citationSun, N., Uda, Y., Azab, E., Kochen, A., Santos, R. N. C. E., Shi, C., Kobayashi, T., Wein, M. N., & Pajevic, P. D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007312 · Cited by 14 · see citing works
Self-citationGuimarães, G. N., Rodrigues, T. L., de Souza, A. P., Line, S. R. P., & Marques, M. R. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9892-1 · Cited by 13 · see citing works
Ho, P. W. M., Chan, A. S. M., Pavlos, N. J., Sims, N. A., & Martin, T. J. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113627 · Cited by 13 · see citing works
Lau, K. ‐. W., Baylink, D. J., & Sheng, M. H. ‐. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115897 · Cited by 13 · see citing works
Effects of selenium-cadmium co-enriched Cardamine hupingshanensis on bone damage in mice
Zhang, L., Shi, W., Zhang, L., Sha, Y., Xu, J., Shen, L.-C., Li, Y.-H., Yuan, L., & Qin, L. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116101 · Cited by 12 · see citing works
Bone: A Neglected Endocrine Organ?
Szeliga, A., Grymowicz, M., Kostrzak, A., Smolarczyk, R., Bala, G. P., Smolarczyk, K., Męczekalski, B., & Suchta, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133889 · Cited by 11 · see citing works
Endosomal signaling via cAMP in parathyroid hormone (PTH) type 1 receptor biology
Pena, K. A., Savransky, S., & Lewis, B. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.112107 · Cited by 11 · see citing works
PTH (1–34) affects bone turnover governed by osteocytes exposed to fluoride
Yu, X., Yu, H., Jiang, N., Zhang, X., Zhang, M., & Xu, H. J. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.02.014 · Cited by 11 · see citing works
Liu, Y., Wu, Y., Diao, Z., Guo, W., & Liu, W. (2019) · Renal Failure · doi:10.1080/0886022x.2019.1605296 · Cited by 11 · see citing works
Li, X.-X., Wang, M.-T., Wu, Z., Sun, Q., Ono, N., Nagata, M., Zang, X., & Ono, W. (2024) · Calcified Tissue International · doi:10.1007/s00223-024-01227-y · Cited by 10 · see citing works
- Authors
- Saini, V., Marengi, D. A., Barry, K. J., Fulzele, K. S., Heiden, E., Liu, X., Dedic, C., Maeda, A., Lotinun, S., Baron, R., & Pajevic, P. D.
- Affiliations
- Harvard University (US)
- Corresponding author
- Pajevic, Paola Divieti
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 288
- Issue
- 28
- Pages
- 20122-20134
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC3711281
- OpenAlex
- W2035856790
- Cited by
- 167
- References
- 31
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 6 · 2020: 19 · 2019: 13 · 2018: 16 · 2017: 14 · 2016: 17 · 2015: 27 · 2014: 16 · 2013: 2 · 2012: 1
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- Tokyo Medical and Dental University
- National Institutes of Health (DK079161)
- National Institute of Diabetes and Digestive and Kidney Diseases (R56DK079161, R01DK079161, DK079161)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR060221)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- parathyroid hormone, osteocytes, bone remodeling, osteoporosis treatment, osteoblast recruitment, osteoclastogenesis, RANKL, sclerostin, bone mineral density
- MeSH terms
- Collagen Type I, alpha 1 Chain, Animals, Body Weight, Bone and Bones, Cells, Cultured, Female, Immunohistochemistry, Male, Osteoclasts, Osteocytes, Parathyroid Hormone, Signal Transduction, Bone Density, Gene Expression, In Situ Hybridization, Reverse Transcriptase Polymerase Chain Reaction, Collagen Type I, Receptor, Parathyroid Hormone, Type 1, Mice, Osteoprotegerin, RANK Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
